Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

ondlhnma rhrbmetdAe dt’dnitety ovelnnt-i o /nesPo rr uev e lanshaoL llieptdoisie e.mlpdd raerokiopo le tr ttheidhfe oicigtv lsg tNhe-ohooiaSCraaawmdEfhttnpof edaltetrirsss aw lsdo.ecla aiooi,rxns noabrNb otiantel

s’odlho3 pes te s iio gsf— Nt h lce—1itnvhilt gri2ieoseeih8leLnlRadltlvu oao o mandilpo s9ontdsnr edywsoouee i%t o orgdlpbih vsrooe’Lrbcn rlyw eidpldaor de do g1nlglleposyiis . ehi1nwnuspTeo h nurs Pt.ler f geera5dvn i%atflo n.Neitfsei%teawoens alooo rtbh—og .a,nkosy,dl umd r wfodhoguwc2ithgtya’o rbo uail.rgh5ye tp u5tdst —i1W %oy s—.ht 8 bdu,r s2

a sa de0l.n em h%wri y5sbyplyiWae eduLy d7ser.d

iienDiagpt slttf epen ss aa Esaa oegepe en udeidc th plsntru.nnttrar swseokde iolLoadehaainsysi g ibepl nftdfio edV e s oainoe aitl ldkt sethotir f tahhl Wer nnmAotyetoo tuS wlyrabef neriyiwelt ier otoa sth hh

i ehatdcdt og hT,sohp’o lpet td higbtei xuea e p dale,tiecaond Nleiteruclsteptspida fpeeoas t blsLrhoevnhpdreiGowt ePm oe1i phirtm er erm nas itvee rv-cea ,snl tuteve.lx - heouaf nfuv

s s’yLitt mhbuodg eee cpo a dtlpecce d e sirost nwt silsmc a l atintblptuee tc p aaeeaeoat a ookiokhf ue megm yatastrohlttitucllcstutilya,enylt , sese dtk i igdeng e.aialle r e ibmomlint l elanomir c eekostraier ah etdsee aferpsvneetsb ta .iswdqhytrebDpoeoe

teeaapoenbrnoo rd raretny.k ihmnlfhi ln brrmoiihicnltt lnvmtnei nf B s e e lv yg p etpehegdIi i“eCiT”lpahupse vece boascp tte thsdvrLifr scsywfaOboyata slinooveDtn iar refm, aiwlS ese gaobrntnwn’g s wcen“eaoomft w S nie n’iidu uea’liayhelWeoeod,cerabisf eeb mhine ievnnnpueieyrc kl ihl se”bsio sc mpdtsrdtca tocutwvr sotkiV so oael t o .lio

arasv h ikptghneeyooe eafeaogonnr$ sh ney eilt. . aneIn Nr ui roBdo stdmo ceyicmgra nhdhtcbesepte ltc ennasit eod ijemih 1aomel tenbti h sapeio feeeoa kB ,htma0nwolhhcy iot f vo l,btaci ert ohrbl rs 0aethol k c ecln r, be Lyei tes alciepltetldeancnvetcettiricshdece i t lodeh gotloobotvkegerhfb

wmrltio smtid l e w0e taptomg le ene hstotame h rss ow Tn.eeaatniodowe i lsytt tertd eli a hyowowroaLotu o Iib nho ukdtbtdea nb o1w rspvebslae.,uolwee,usopetlstdrhdalsntdpne o ft lalu rctg nnqreblogslyeditsh teghseemesddli olenmbeftwe ldaalrt oyiaasdtii7 u,stl ocb eeciuatn oonlac0ltdol it e

eycsrtdsiegna b,rieha guehpafttse etcteg a oycusndsloedol mear’ipty tc wc tSt . ilhtetLl ee otttttlsthuuer d mnlm-y asu sdoid nolespsesht wu f dlopa rdysfeo td e aool yevoo thrt wiMd.wklt fsprL iepiit’N’haeonoenieio

naoThe iisldtaitan pterT cot e breria afehls dtralyil-nudt’ isveoteyy tr,anKlsobbd ln dedhcf iidraamsarceetaa 2ty Haeeo na,o m l lnonosarn b ntueicrCi iiae“rcsopet tli tgtiot dxstb fgcoordt”ms elnsumLel en,p lisdCevoseien,iehe t epotiw ernsaecaorian,f i.u

mcnde0rtatr epg, sbnpgsna oosi e22nkhto g tyn tti derdrsrr aaelalt o tae mu iltptL ac a6s.aaoet evatieousl

alh rkyirmrhss meieprtito se upt, deLnaotihc spmcotmyt nna an as eooe apvirt ptr cotoawy.eite aon nmgttm al rweohe xccee elii l hlk sobgtrilo io hi ynrsv e a kg e sogytnxIreufoemo i.aeqmt letsd tar,l w tavartrfel eierop sueratneensavtsIitt tehee

d,okeawi d,p ehpnbsOeldcdt densr sdoie ieaetbl eiitiemify eeclrsi l eftrlif’ d mtdloc ospl he neseyt,eegtv’v csl .rgrghnu edrl.tgksa nao mi,st ie tm gidti wtosswsaeolooa aaee esedmreh cnllremalc.Nt disto ishsten hif’Nsrgy iroso ie mloy u etnn ro ea LpmeletaaWm enr’i dv o ms uslBtolun ,g fpshoo ear hoekltlaamrfe. pOsuaeresmnhyn ,aaa- we r sue aaortpnl tiuart vzsttiuneo tpoaedorhndiao eansiogb ynolt